Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.

Michelle D Hackshaw,Christine L Bui,Amy Ladner, Nora Tu, Zahidul Islam,Mary E Ritchey,Maribel Salas

Cancer treatment and research communications（2020）

引用 3|浏览2

暂无评分

摘要

The treatment patterns and clinical outcomes observed in this literature review suggest patients treated with trastuzumab have longer survival times compared with chemotherapy treatment alone and tolerate treatment.

查看译文

关键词

Anti-HER2 therapy,HER2,Metastatic gastric cancer,Review,Trastuzumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要